Valuation (12%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -5.46 | N/A |
| PEG Ratio (TTM) | -0.08 | N/A |
| P/S Ratio (TTM) | 0.46 | N/A |
| P/B Ratio (TTM) | -14.16 | N/A |
| P/FCF Ratio (TTM) | -8.58 | N/A |
| Price to 5YR AVG Earnings Ratio | -2.59 | N/A |
| Price to 5YR AVG FCF Ratio | 170.52 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -5.16% | N/A |
| ROE (TTM) | 192.61% | N/A |
| Net Profit Margin (TTM) | -9.51% | N/A |
| ROIC 5YR AVG | -2.97% | N/A |
Growth (2%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -7.18% | -121.09% | -236.03% |
| Revenue | -0.26% | -0.01% | 2.22% |
| Net Income | -18.67% | -128.23% | -244.44% |
| Cash Flow | -872.20% | -44,045.44% | -26,321.29% |
Health (12%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.30 | N/A |
| Quick Ratio (TTM) | 0.30 | N/A |
| D/E Ratio (TTM) | -17.31 | N/A |
| Interest Coverage (TTM) | 0.34 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | 241.45 | N/A |
| Shares Outstanding Growth 5YR AVG | 1.85% | N/A |